Showing results (1-10 of 172) with videos related to
Sort By:
Pageof 18
Drug Safety|November 7, 2019
Medical Devices: Classification and Analysis of Faults Leading to HarmsRobin E Ferner, Jeffrey K AronsonBritish Journal of Clinical Pharmacology|July 16, 2015
Cato Guldberg and Peter Waage, the history of the Law of Mass Action, and its relevance to clinical pharmacologyRobin E Ferner, Jeffrey K AronsonDrug Safety|October 8, 2010
Preventability of drug-related harms - part I: a systematic reviewRobin E Ferner, Jeffrey K AronsonDrug Safety|October 8, 2010
Preventability of drug-related harms - part II: proposed criteria, based on frameworks that classify adverse drug reactionsJeffrey K Aronson, Robin E FernerBritish Journal of Clinical Pharmacology|June 30, 2015
The law of mass action and the pharmacological concentration-effect curve: resolving the paradox of apparently non-dose-related adverse drug reactionsJeffrey K Aronson, Robin E FernerBritish Journal of Clinical Pharmacology|August 6, 2017
Unlicensed and off-label uses of medicines: definitions and clarification of terminologyJeffrey K Aronson, Robin E FernerBMJ (Clinical Research Ed.)|December 16, 2016
Nominal ISOMERs (Incorrect Spellings Of Medicines Eluding Researchers)-variants in the spellings of drug names in PubMed: a database reviewRobin E Ferner, Jeffrey K AronsonCurrent Protocols in Pharmacology|March 18, 2017
Biomarkers-A General ReviewJeffrey K Aronson, Robin E FernerDrug Safety|December 17, 2009
EIDOS: a mechanistic classification of adverse drug effectsRobin E Ferner, Jeffrey K AronsonDrug Safety|May 1, 2024
Competing Benefits and Competing Hazards: The Benefit to Harm Balance in Individual Patients in Rational TherapeuticsRobin E Ferner, Jeffrey K AronsonPageof 18